CANCER IMMUNOLOGY IMMUNOTHERAPY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095784, encodeId=52f82095e8422, content=有大神知道投稿页面显示，“you do not have sufficient permissions to view this page”是因为啥嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Mon Oct 24 13:23:13 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225130, encodeId=caf512251300f, content=求助，这个期刊投稿界面为什么不能投稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1db25229169, createdName=1479858am29(暂无昵称), createdTime=Wed Jun 08 08:28:17 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190583, encodeId=6691119058331, content=偏重的研究方向：肿瘤 经验分享：请问各位师兄，师姐，under review快一年了，从3个月起发了好多邮件都没回复，这种情况该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:35:01 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224021, encodeId=a126122402156, content=请问这家杂志收纯生信么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14755273664, createdName=1482a8b3m96(暂无昵称), createdTime=Thu Jun 02 11:23:28 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2021-10-06 Ykkkk

请问文章接收多久后能收到版权协议和proof？

68 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095784, encodeId=52f82095e8422, content=有大神知道投稿页面显示，“you do not have sufficient permissions to view this page”是因为啥嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Mon Oct 24 13:23:13 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225130, encodeId=caf512251300f, content=求助，这个期刊投稿界面为什么不能投稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1db25229169, createdName=1479858am29(暂无昵称), createdTime=Wed Jun 08 08:28:17 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190583, encodeId=6691119058331, content=偏重的研究方向：肿瘤 经验分享：请问各位师兄，师姐，under review快一年了，从3个月起发了好多邮件都没回复，这种情况该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:35:01 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224021, encodeId=a126122402156, content=请问这家杂志收纯生信么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14755273664, createdName=1482a8b3m96(暂无昵称), createdTime=Thu Jun 02 11:23:28 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2022-08-24 ms3000000087643737

请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。

65 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095784, encodeId=52f82095e8422, content=有大神知道投稿页面显示，“you do not have sufficient permissions to view this page”是因为啥嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Mon Oct 24 13:23:13 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225130, encodeId=caf512251300f, content=求助，这个期刊投稿界面为什么不能投稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1db25229169, createdName=1479858am29(暂无昵称), createdTime=Wed Jun 08 08:28:17 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190583, encodeId=6691119058331, content=偏重的研究方向：肿瘤 经验分享：请问各位师兄，师姐，under review快一年了，从3个月起发了好多邮件都没回复，这种情况该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:35:01 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224021, encodeId=a126122402156, content=请问这家杂志收纯生信么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14755273664, createdName=1482a8b3m96(暂无昵称), createdTime=Thu Jun 02 11:23:28 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2022-12-24 actin 5 来自湖北省

审稿速度:4.0
偏重的研究方向：免疫;肿瘤免疫
经验分享：变三区了，性价比不高

54 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095784, encodeId=52f82095e8422, content=有大神知道投稿页面显示，“you do not have sufficient permissions to view this page”是因为啥嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Mon Oct 24 13:23:13 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225130, encodeId=caf512251300f, content=求助，这个期刊投稿界面为什么不能投稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1db25229169, createdName=1479858am29(暂无昵称), createdTime=Wed Jun 08 08:28:17 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190583, encodeId=6691119058331, content=偏重的研究方向：肿瘤 经验分享：请问各位师兄，师姐，under review快一年了，从3个月起发了好多邮件都没回复，这种情况该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:35:01 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224021, encodeId=a126122402156, content=请问这家杂志收纯生信么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14755273664, createdName=1482a8b3m96(暂无昵称), createdTime=Thu Jun 02 11:23:28 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2022-09-02 ms3000001278720978

偏重的研究方向：肿瘤
经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办

59 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095784, encodeId=52f82095e8422, content=有大神知道投稿页面显示，“you do not have sufficient permissions to view this page”是因为啥嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Mon Oct 24 13:23:13 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225130, encodeId=caf512251300f, content=求助，这个期刊投稿界面为什么不能投稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1db25229169, createdName=1479858am29(暂无昵称), createdTime=Wed Jun 08 08:28:17 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190583, encodeId=6691119058331, content=偏重的研究方向：肿瘤 经验分享：请问各位师兄，师姐，under review快一年了，从3个月起发了好多邮件都没回复，这种情况该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:35:01 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224021, encodeId=a126122402156, content=请问这家杂志收纯生信么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14755273664, createdName=1482a8b3m96(暂无昵称), createdTime=Thu Jun 02 11:23:28 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2022-11-07 ms1000001339998745

审稿速度:6.0 | 投稿命中率:25.0
经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿

53 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095784, encodeId=52f82095e8422, content=有大神知道投稿页面显示，“you do not have sufficient permissions to view this page”是因为啥嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Mon Oct 24 13:23:13 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225130, encodeId=caf512251300f, content=求助，这个期刊投稿界面为什么不能投稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1db25229169, createdName=1479858am29(暂无昵称), createdTime=Wed Jun 08 08:28:17 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190583, encodeId=6691119058331, content=偏重的研究方向：肿瘤 经验分享：请问各位师兄，师姐，under review快一年了，从3个月起发了好多邮件都没回复，这种情况该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:35:01 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224021, encodeId=a126122402156, content=请问这家杂志收纯生信么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14755273664, createdName=1482a8b3m96(暂无昵称), createdTime=Thu Jun 02 11:23:28 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2022-10-19 ms6000002045898850

想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢

60 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095784, encodeId=52f82095e8422, content=有大神知道投稿页面显示，“you do not have sufficient permissions to view this page”是因为啥嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Mon Oct 24 13:23:13 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225130, encodeId=caf512251300f, content=求助，这个期刊投稿界面为什么不能投稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1db25229169, createdName=1479858am29(暂无昵称), createdTime=Wed Jun 08 08:28:17 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190583, encodeId=6691119058331, content=偏重的研究方向：肿瘤 经验分享：请问各位师兄，师姐，under review快一年了，从3个月起发了好多邮件都没回复，这种情况该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:35:01 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224021, encodeId=a126122402156, content=请问这家杂志收纯生信么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14755273664, createdName=1482a8b3m96(暂无昵称), createdTime=Thu Jun 02 11:23:28 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2022-10-24 ms6000002045898850

有大神知道投稿页面显示，“you do not have sufficient permissions to view this page”是因为啥嘛

53 0

[GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095784, encodeId=52f82095e8422, content=有大神知道投稿页面显示，“you do not have sufficient permissions to view this page”是因为啥嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Mon Oct 24 13:23:13 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225130, encodeId=caf512251300f, content=求助，这个期刊投稿界面为什么不能投稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1db25229169, createdName=1479858am29(暂无昵称), createdTime=Wed Jun 08 08:28:17 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190583, encodeId=6691119058331, content=偏重的研究方向：肿瘤 经验分享：请问各位师兄，师姐，under review快一年了，从3个月起发了好多邮件都没回复，这种情况该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:35:01 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224021, encodeId=a126122402156, content=请问这家杂志收纯生信么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14755273664, createdName=1482a8b3m96(暂无昵称), createdTime=Thu Jun 02 11:23:28 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2022-06-08 1479858am29(暂无昵称)

求助，这个期刊投稿界面为什么不能投稿呢

66 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095784, encodeId=52f82095e8422, content=有大神知道投稿页面显示，“you do not have sufficient permissions to view this page”是因为啥嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Mon Oct 24 13:23:13 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225130, encodeId=caf512251300f, content=求助，这个期刊投稿界面为什么不能投稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1db25229169, createdName=1479858am29(暂无昵称), createdTime=Wed Jun 08 08:28:17 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190583, encodeId=6691119058331, content=偏重的研究方向：肿瘤 经验分享：请问各位师兄，师姐，under review快一年了，从3个月起发了好多邮件都没回复，这种情况该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:35:01 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224021, encodeId=a126122402156, content=请问这家杂志收纯生信么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14755273664, createdName=1482a8b3m96(暂无昵称), createdTime=Thu Jun 02 11:23:28 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2022-02-06 148202a4m20(暂无昵称)

偏重的研究方向：肿瘤
经验分享：请问各位师兄，师姐，under review快一年了，从3个月起发了好多邮件都没回复，这种情况该怎么办？

1 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤 经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095784, encodeId=52f82095e8422, content=有大神知道投稿页面显示，“you do not have sufficient permissions to view this page”是因为啥嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Mon Oct 24 13:23:13 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225130, encodeId=caf512251300f, content=求助，这个期刊投稿界面为什么不能投稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1db25229169, createdName=1479858am29(暂无昵称), createdTime=Wed Jun 08 08:28:17 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190583, encodeId=6691119058331, content=偏重的研究方向：肿瘤 经验分享：请问各位师兄，师姐，under review快一年了，从3个月起发了好多邮件都没回复，这种情况该怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:35:01 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224021, encodeId=a126122402156, content=请问这家杂志收纯生信么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14755273664, createdName=1482a8b3m96(暂无昵称), createdTime=Thu Jun 02 11:23:28 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2022-06-02 1482a8b3m96(暂无昵称)

请问这家杂志收纯生信么

62 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务